Press Releases for SGMO

Press Releases
Sangamo BioSciences Reports Second Quarter 2009 Financial Results
OMT Announces a Breakthrough in the Development of a Novel Human Antibody Platform
Researchers Create First Targeted Knockout Rats Using Zinc Finger Nuclease Technology
Sangamo BioSciences Announces Second Quarter 2009 Conference Call and Webcast
Dyax Corp. Announces Second Quarter 2009 Financial Results
Sangamo BioSciences Announces Achievement of Key Milestone in Cell Engineering Agreement With Genentech
Sangamo BioSciences Presents Positive Phase 2 ZFP Therapeutic Data at ADA 2009
Sangamo BioSciences Announces Presentation at the Needham Life Sciences Conference
Sangamo BioSciences Announces Presentation at the JMP Securities Research Conference
Sangamo BioSciences Receives $100,000 Grand Challenges Explorations Grant for Innovative Global Health Research
Sangamo BioSciences Reports First Quarter 2009 Financial Results
Sangamo BioSciences Announces Publication in Nature of the Use of Zinc Finger Nucleases to Accelerate Precision Trait Stacking in Commercial Crop Species
Sangamo BioSciences Announces Presentations at Two Upcoming Investor Conferences
Sangamo BioSciences Reports Fourth Quarter and Full Year 2008 Financial Results
Sangamo BioSciences Initiates Phase 1 Trial of CCR5-ZFP Therapeutic to Treat HIV/AIDS
Sangamo BioSciences Announces Fourth Quarter and Year-End 2008 Conference Call and Webcast
Sigma-Aldrich and Sangamo BioSciences Announce the Achievement of Key Throughput Milestone in Research Reagents Agreement
Sangamo BioSciences to Present at the 27th Annual J.P. Morgan Healthcare Conference
Sangamo BioSciences Announces License Agreement With Pfizer for Zinc Finger Nucleases for Protein Production
Sangamo BioSciences Provides Update on Company's 2008 Progress and 2009 Objectives
Sangamo BioSciences to Webcast Annual Investor and Analyst Briefing and Presentation at Piper Jaffray Health Care Conference
Sangamo BioSciences Appoints Paul Cleveland to Its Board of Directors and Chair of Audit Committee
Sangamo BioSciences Announces Results From Diabetic Neuropathy Clinical Trial SB-509-601
Sangamo BioSciences Reports Third Quarter 2008 Financial Results
Sangamo BioSciences Presents Data at ICAAC Demonstrating 'In Vivo' Protection Against HIV Infection by CCR5-ZFN Therapeutic
Sangamo BioSciences Announces Third Quarter Conference Call and Webcast
Zacks Analyst Blog Highlights: Everest Re Group, Ltd., State Auto Financial Corp., Sangamo Biosciences, Inc., Lloyds TSB Group Plc. And HBOS Plc.
Zacks Bull and Bear of the Day Highlights: St. Jude Medical, AAR Corp., Sangamo Biosciences, State Auto Financial and Robert Half
Sangamo BioSciences to Present at Two Upcoming Investor Conferences
Sangamo BioSciences to Present at the UBS Global Life Sciences Conference
Sigma-Aldrich Launches Breakthrough Genome-Editing Tools
Sangamo BioSciences Announces Presentation of Data From Diabetic Neuropathy Clinical Trials
Sangamo BioSciences Initiates Phase 2 Clinical Trial of Treatment for Amyotrophic Lateral Sclerosis (ALS)
Sangamo BioSciences to Present at the Canaccord Adams Global Growth Conference
Sangamo BioSciences to Present at the BMO Capital Markets Focus on Healthcare Conference
Sangamo BioSciences Reports Second Quarter 2008 Financial Results
Sangamo BioSciences Announces Second Quarter Conference Call and Webcast
Zacks Analyst Blog Highlights: Sangamo Biosciences, Dow AgroSciences, Sigma-Aldrich, Genentech and Progressive Corp. - Business Wire
Sangamo BioSciences and Sigma-Aldrich Announce Research and License Agreement With Roche for the Use of ZFN Technology for Generation of Transgenic Animals
Sangamo BioSciences Announces Nature Biotechnology Study Demonstrating the Use of Zinc Finger Nucleases to Generate HIV Resistant T Cells
Dow AgroSciences Announces Early Exercise of Option for Commercial License With Sangamo BioSciences for Plants
Sangamo BioSciences Announces Presentation of Phase 1b ZFP Therapeutic Data at American Diabetes Association Meeting
Sangamo BioSciences Provides Update on Diabetic Neuropathy Clinical Programs
Dow AgroSciences, Sangamo BioSciences Announce the Achievement of Key Milestones in Plant Agriculture Collaboration
Sangamo BioSciences to Present at the Canaccord Adams Diabetes and Obesity Conference
New Analyst Reports for ROCKWELL DIAMONDS INC, GENVEC INC, SANGAMO BIOSCIENCES INC, and ZYMOGENETICS INC
Sangamo BioSciences Announces Presentation of Phase 1 Data of ZFP Therapeutic at International Society for Cellular Therapy (ISCT) Meeting - May 27 2008 12:56AM
Sangamo BioSciences to Present at the Citi Investment Research Global Healthcare Conference - May 27 2008 12:53AM
Sangamo BioSciences to Present at the 7th Annual JMP Securities Research Conference - Jun 2 2008 3:53AM
Sangamo BioSciences to Present at the Bank of America 2008 Healthcare Conference - Jun 2 2008 3:53AM
Sangamo BioSciences Reports First Quarter 2008 Financial Results
Sangamo BioSciences Nominates Thomas G. Wiggans to Its Board of Directors
Sangamo BioSciences Announces First Quarter Conference Call and Webcast
Sangamo BioSciences Announces Presentation of Data on ZFP Therapeutic for Glioblastoma at American Association for Cancer Research (AACR) Meeting
Sangamo BioSciences Announces License Agreement For the Use of ZFP Technology For Generation of Transgenic Animals